The British scientists are now keen on developing a blood test for the liver disease. It is being said that the test for the liver disease will be able to diagnose the illness ten years before the onset of symptoms for the same.

This blood test can be carried out in GP surgeries. It gives the results within thirty minutes of sample collection. Meanwhile, the patients can have their sip of tea or coffee.

The team involves a group of researchers from the University College London. The research team says that the approximate cost of the test will be less than £50. It will help in identifying the liver disorder about ten to twenty years before the symptoms arrive. The researchers hope that the test will be made available within a span of about five to ten years.

The liver disorder ranks fifth amongst the killer diseases in the United Kingdom. It is one of those significant illnesses where the death rate is exhibiting only an exponential growth curve. As per the recent statistics, the liver diseases have claimed about eleven thousand and six hundred deaths in the year 2014. When the figure is compared with the statistics in the year 2001, there has been an increase of about twenty-five percent.

The primary factors that contribute to the liver disorders are the obesity and alcohol. Symptoms occur in the later phase, and hence people are diagnosed with the liver disorders once the illness advances.

The study makes its way to the Advanced Materials. It describes the new technique to detect the liver fibrosis. The liver fibrosis is the first screening stage of the liver scarring which leads to the fatal liver disease. The condition worsens further if the situation is left unaddressed for a more extended period.

Professor William Rosenberg says, “Liver disease is the third largest cause of premature mortality in the UK, and one of the only leading causes of death that’s on the increase. We hope that our new test could be used on a routine basis in GP surgeries and hospital clinics to screen people who face an elevated risk of the liver disease, but don’t yet show signs of the liver damage to identify those with serious fibrosis, so that they can access treatment before its too late.” Professor William Rosenberg hails from UCL.